P53-Mdm2 Pathway: Evidences for a New Targeted Therapeutic Approach in B-Acute Lymphoblastic Leukemia
Frontiers in Pharmacology - Switzerland
doi 10.3389/fphar.2016.00491
Full Text
Open PDFAbstract
Available in full text
Categories
Date
December 16, 2016
Authors
Publisher
Frontiers Media SA